Your browser doesn't support javascript.
loading
Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
Woo-Jin CHUNG.
Clinical and Molecular Hepatology ; : 268-271, 2012.
Article in En | WPRIM | ID: wpr-210179
Responsible library: WPRO
ABSTRACT
No abstract available.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Index: WPRIM Main subject: Antiviral Agents / Polyethylene Glycols / Ribavirin / Recombinant Proteins / Interferon-alpha / Hepatitis C, Chronic Limits: Female / Humans / Male Language: En Journal: Clinical and Molecular Hepatology Year: 2012 Type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Index: WPRIM Main subject: Antiviral Agents / Polyethylene Glycols / Ribavirin / Recombinant Proteins / Interferon-alpha / Hepatitis C, Chronic Limits: Female / Humans / Male Language: En Journal: Clinical and Molecular Hepatology Year: 2012 Type: Article